首页> 外文期刊>Cancer Biomarkers >BBC3 is down-regulated with increased tumor size independently of p53 expression in head and neck cancer
【24h】

BBC3 is down-regulated with increased tumor size independently of p53 expression in head and neck cancer

机译:BBC3被下调,肿瘤大小增加与头颈癌中p53表达无关

获取原文
获取原文并翻译 | 示例
           

摘要

The study focuses on BBC3 gene expression in primary head and neck squamous cell carcinomas (HNSCC) in relation to pTNM classification. We used quantitative real-time PCR on 35 biopsy samples of HNSCC tumor samples to evaluate differences of BBC3 expression depending on tumor size, regional lymph node involvement, location and tumor staging. In order to confirm the model of BBC3-mediated apoptosis, we used immunohistochemistry to determine the expression of apoptotic proteins p53, p63, Bcl-2 and Bax. We also used publicly available cDNA microarray datasets. Our results show a general down-regulation of BBC3 in tumor tissue compared to adjacent normal tissue. The expression was significantly altered among different groups of patho-histologically evaluated tumor sizes, but not in relation to tumor location, regional lymph node involvement or tumor stage. That suggests the potential use of BBC3 as a new tumor size marker in HNSCC. Through protein expression analysis combined with publicly available cDNA microarray datasets of apoptotic factors, we confirmed the model of BBC3-mediated apoptosis, which can be activated with or without p53.
机译:这项研究集中在与pTNM分类有关的原发性头颈部鳞状细胞癌(HNSCC)中BBC3基因的表达。我们在35例HNSCC肿瘤样本的活检样本中使用了定量实时PCR,以评估BBC3表达的差异,具体取决于肿瘤大小,区域淋巴结受累,位置和肿瘤分期。为了证实BBC3介导的凋亡模型,我们使用了免疫组织化学方法来确定凋亡蛋白p53,p63,Bcl-2和Bax的表达。我们还使用了公开可用的cDNA微阵列数据集。我们的结果显示,与邻近的正常组织相比,肿瘤组织中的BBC3普遍下调。在经过病理组织学评估的不同肿瘤大小之间,表达明显改变,但与肿瘤位置,区域淋巴结受累或肿瘤分期无关。这表明在HNSCC中潜在使用BBC3作为新的肿瘤大小标记。通过蛋白质表达分析与凋亡因子的公开可获得的cDNA微阵列数据集相结合,我们证实了BBC3介导的凋亡模型,无论是否存在p53均可激活该模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号